Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial (Q34025831)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial |
scientific article |
Statements
1 reference
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial (English)
1 reference
Peter Malfertheiner
1 reference
Francis Mégraud
1 reference
Franco Bazzoli
1 reference
Jean-Charles Delchier
1 reference
Krysztof Celiñski
1 reference
Monique Giguère
1 reference
Marc Rivière
1 reference
Pylera Study Group
1 reference
21 February 2011
1 reference
Identifiers
1 reference